| Primary |
| Constipation |
18.2% |
| Parkinson's Disease |
18.2% |
| Urinary Tract Infection |
18.2% |
| Atrial Fibrillation |
9.1% |
| Atrial Flutter |
9.1% |
| Benign Prostatic Hyperplasia |
9.1% |
| Congenital Neuropathy |
9.1% |
| Neuropathy Peripheral |
9.1% |
|
| Cholestatic Liver Injury |
100.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
11.8% |
| Renal Transplant |
9.8% |
| Hypertension |
8.8% |
| Colitis Ulcerative |
6.9% |
| Sarcoidosis |
6.9% |
| Polyarthritis |
5.9% |
| Product Used For Unknown Indication |
5.9% |
| Bacterial Infection |
4.9% |
| Anaemia |
3.9% |
| Crohn's Disease |
3.9% |
| Juvenile Arthritis |
3.9% |
| Myasthenia Gravis |
3.9% |
| Polyarteritis Nodosa |
3.9% |
| Systemic Lupus Erythematosus |
3.9% |
| Endocarditis |
2.9% |
| Essential Hypertension |
2.9% |
| Pain |
2.9% |
| Pruritus |
2.9% |
| Candidiasis |
2.0% |
| Computerised Tomogram Abdomen |
2.0% |
|
| Pancreatitis Acute |
12.9% |
| Systemic Lupus Erythematosus |
12.9% |
| Pancytopenia |
9.7% |
| Drug Exposure During Pregnancy |
6.5% |
| Pancreatitis |
6.5% |
| Skin Ulcer |
6.5% |
| Bone Marrow Failure |
3.2% |
| Disseminated Tuberculosis |
3.2% |
| Drug Ineffective |
3.2% |
| Malaise |
3.2% |
| Nausea |
3.2% |
| Pneumonia Bacterial |
3.2% |
| Pneumonia Staphylococcal |
3.2% |
| Prostate Cancer Metastatic |
3.2% |
| Renal Disorder |
3.2% |
| Speech Disorder |
3.2% |
| Thrombocytopenia |
3.2% |
| Toxic Epidermal Necrolysis |
3.2% |
| Vaginal Fistula |
3.2% |
| Viral Test Positive |
3.2% |
|
| Concomitant |
| Crohn's Disease |
26.6% |
| Drug Use For Unknown Indication |
17.7% |
| Renal Transplant |
8.6% |
| Product Used For Unknown Indication |
7.2% |
| Osteoporosis |
3.9% |
| Pain |
3.9% |
| Rheumatoid Arthritis |
3.6% |
| Multiple Sclerosis |
3.0% |
| Depression |
2.8% |
| Hypertension |
2.8% |
| Colitis Ulcerative |
2.5% |
| Liver Transplant |
2.5% |
| Abscess |
2.2% |
| Erythema Nodosum |
2.2% |
| Polyarthritis |
2.2% |
| Relapsing-remitting Multiple Sclerosis |
1.9% |
| Systemic Lupus Erythematosus |
1.9% |
| Coronary Artery Disease |
1.7% |
| Hypercholesterolaemia |
1.4% |
| Prophylaxis |
1.4% |
|
| Hepatic Fibrosis |
10.2% |
| Pneumonia Primary Atypical |
10.2% |
| Progressive Multifocal Leukoencephalopathy |
8.5% |
| Disseminated Tuberculosis |
6.8% |
| Toxoplasmosis |
6.8% |
| Myocardial Infarction |
5.1% |
| Renal Failure |
5.1% |
| Sepsis |
5.1% |
| Wound Dehiscence |
5.1% |
| Anaemia |
3.4% |
| Bone Marrow Failure |
3.4% |
| Diarrhoea |
3.4% |
| Drug Interaction |
3.4% |
| Femur Fracture |
3.4% |
| Gastrointestinal Injury |
3.4% |
| Grand Mal Convulsion |
3.4% |
| Hodgkin's Disease |
3.4% |
| Leiomyosarcoma |
3.4% |
| Myocardial Ischaemia |
3.4% |
| Paraesthesia |
3.4% |
|
| Interacting |
| Nephrotic Syndrome |
50.0% |
| Renal Transplant |
50.0% |
|
| Renal Cell Carcinoma |
100.0% |
|
